Patient Guide: Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 72 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02584933
Status: ACTIVE_NOT_RECRUITING
Condition: ALK Positive Malignancies
Phase: PHASE4

Where You Can Participate

This study is available at 72 locations across the country.

Top locations include:
  • • Fayetteville, Arkansas
  • • Loma Linda, California
  • • Aurora, Colorado
  • • And 69 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study - Join Clinical Trial NCTNCT02584933

How to Join This Clinical Trial - NCTNCT02584933

Learn how to participate in this PHASE4 trial studying an investigational therapy for ALK Positive Malignancies. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with ALK Positive Malignancies. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
ALK Positive Malignancies
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT02584933 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 72 locations. Find a study site near you:

Clinical Research Site

Fayetteville, Arkansas 72703 - United States

Status: Contact for availability

Clinical Research Site

Loma Linda, California 92354 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Rockville, Maryland 20850 - United States

Status: Contact for availability

Clinical Research Site

Belleville, New Jersey 07109 - United States

Status: Contact for availability

Clinical Research Site

Melbourne, Victoria 3000 - Australia

Status: Contact for availability

Clinical Research Site

Auckland, 1023 - Australia

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 90610-000 - Brazil

Status: Contact for availability

Clinical Research Site

Natal, RN 59075 740 - Brazil

Status: Contact for availability

And 62 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for ALK Positive Malignancies:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships